ASP
CRVS icon

Adams Street Partners’s Corvus Pharmaceuticals CRVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.1M Hold
3,275,616
9.23% 3
2025
Q1
$10.4M Hold
3,275,616
9.22% 3
2024
Q4
$17.5M Hold
3,275,616
15.53% 2
2024
Q3
$17.3M Hold
3,275,616
9.52% 5
2024
Q2
$5.96M Hold
3,275,616
2.46% 6
2024
Q1
$5.83M Hold
3,275,616
2.32% 7
2023
Q4
$5.77M Hold
3,275,616
1.78% 9
2023
Q3
$4.78M Hold
3,275,616
1.67% 9
2023
Q2
$7.5M Hold
3,275,616
1.96% 10
2023
Q1
$2.98M Hold
3,275,616
0.93% 8
2022
Q4
$2.78M Hold
3,275,616
0.93% 9
2022
Q3
$2.68M Hold
3,275,616
0.73% 9
2022
Q2
$3.24M Hold
3,275,616
0.84% 9
2022
Q1
$5.37M Hold
3,275,616
0.99% 9
2021
Q4
$7.89M Hold
3,275,616
1.2% 10
2021
Q3
$15.9M Hold
3,275,616
2.03% 9
2021
Q2
$8.75M Hold
3,275,616
1.82% 8
2021
Q1
$10.1M Hold
3,275,616
1.62% 10
2020
Q4
$11.7M Hold
3,275,616
2.42% 6
2020
Q3
$13.1M Hold
3,275,616
3.46% 6
2020
Q2
$8.91M Hold
3,275,616
1.84% 6
2020
Q1
$6.91M Hold
3,275,616
1.72% 5
2019
Q4
$17.8M Hold
3,275,616
3.64% 4
2019
Q3
$9.86M Hold
3,275,616
1.97% 6
2019
Q2
$12.3M Hold
3,275,616
2.27% 7
2019
Q1
$13.2M Hold
3,275,616
2.55% 6
2018
Q4
$12M Hold
3,275,616
2.52% 6
2018
Q3
$28.1M Hold
3,275,616
4.42% 5
2018
Q2
$36M Hold
3,275,616
5.51% 5
2018
Q1
$34M Buy
3,275,616
+588,235
+22% +$6.1M 6.48% 4
2017
Q4
$27.8M Hold
2,687,381
6.61% 4
2017
Q3
$42.8M Hold
2,687,381
10.94% 3
2017
Q2
$32.5M Hold
2,687,381
7.63% 3
2017
Q1
$55.8M Hold
2,687,381
13.73% 3
2016
Q4
$38.4M Hold
2,687,381
10.58% 3
2016
Q3
$44.2M Hold
2,687,381
8.33% 4
2016
Q2
$28.7M Hold
2,687,381
4.7% 4
2016
Q1
$29.2M Buy
+2,687,381
New +$29.2M 5.33% 5